These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34740761)

  • 1. Lipid-microparticles for pulmonary delivery of active pharmaceutical ingredients: Impact of lipid crystallization on spray-drying processability.
    Corzo C; Fuchsbichler A; Savencu I; Afonso Urich J; Zimmer A; Lochmann D; Reyer S; Salar-Behzadi S
    Int J Pharm; 2021 Dec; 610():121259. PubMed ID: 34740761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung.
    Corzo C; Crvenjak D; Sotirov K; Afonso Urich J; Öhlinger K; Meindl C; Lochmann D; Reyer S; Fröhlich E; Zimmer A; Salar-Behzadi S
    Int J Pharm; 2023 Jul; 642():123201. PubMed ID: 37406948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
    Leng D; Thanki K; Foged C; Yang M
    Pharm Res; 2018 Nov; 35(12):247. PubMed ID: 30386927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable microparticle platform based on a novel shell-forming lipid excipient and its feasibility for respirable delivery of biologics.
    Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Vehring R
    Eur J Pharm Biopharm; 2022 Aug; 177():308-322. PubMed ID: 35905804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S; Süverkrüp R; Lamprecht A
    Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
    Amaro MI; Tajber L; Corrigan OI; Healy AM
    Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
    Li X; Mansour HM
    AAPS PharmSciTech; 2011 Dec; 12(4):1420-30. PubMed ID: 22038473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Lipidic Excipients on the Particle Properties and Aerosol Performance of High Drug Load Spray Dried Particles for Inhalation.
    Shetty N; Hau J; Yanez E; Shur J; Cheng J; Sun CC; Nagapudi K; Narang A
    J Pharm Sci; 2022 Apr; 111(4):1152-1163. PubMed ID: 34506865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology.
    Tse JY; Kadota K; Imakubo T; Uchiyama H; Tozuka Y
    Eur J Pharm Sci; 2021 Jan; 156():105600. PubMed ID: 33075466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
    Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
    Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Solvato-) polymorphism of formulations of rifampicin for pulmonary drug delivery prepared using a crystallization/spray drying process.
    Berkenfeld K; McConville JT; Lamprecht A
    Int J Pharm; 2020 Nov; 590():119932. PubMed ID: 33011253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucine as an excipient in spray dried powder for inhalation.
    Alhajj N; O'Reilly NJ; Cathcart H
    Drug Discov Today; 2021 Oct; 26(10):2384-2396. PubMed ID: 33872799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.